2m 2m 2m 2m 2m 2m 2m
Exelixis (EXEL)
NASDAQ
$70.25-$0.33 (-0.47%)
Price as of Nov 11, 2026 7:12 PM EST- $17.2BMarket Cap
- 64.24%1-Year Change
- BiotechnologyIndustry
Exelixis (EXEL)
$70.25-$0.33 (-0.47%)
EXEL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $70.58 | ||
Change | -$1.16 (-1.62%) | ||
Open | $71.56 | ||
High | $72.14 | ||
Low | $69.74 | ||
Previous Close | $71.74 | ||
Volume | 5,583,516 | ||
30-Day Average Volume | 2,972,840 | ||
1-Week Change | -2.39% | ||
1-Month Change | 17.91% | ||
1-Year Change | 64.24% | ||
3-Year Change | 236.10% | ||
5-Year Change | 284.84% | ||
Fundamentals | |||
Shares Outstanding | 244.0M | ||
Total Assets | $2.5B | ||
Market Cap | $17.2B | ||
Enterprise Value | $16.9B | ||
Period: QTR TTM FY | |||
Revenue | $604.9M | ||
Net Income | $218.1M | ||
Free Cash Flow | $277.5M | ||
EBIT | $282.8M | ||
EBITDA | $289.7M | ||
Net Working Capital | $909.7M | ||
EPS | $0.85 | ||
Enterprise Value/EBITDA | 58 | ||
Enterprise Value/Revenue | 28 | ||
P/B | 9 | ||
P/E | 83 | ||
PEG | 23 | ||
Price/Free Cash Flow | 62 | ||
Price/Operating Cash Flow | 62 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue